Galderma R&d

This study aims to see how well the approved drug nemolizumab works for people with moderate-to-severe eczema (atopic dermatitis) in real-world clinic settings. It will follow about 1000 adolescents and adults for up to a year, tracking their skin condition, itch, sleep, and pain…

This study is testing whether a cream called trifarotene works better than a placebo cream to treat moderate acne on the face and body. About 561 Chinese participants aged 9 and older will apply the cream once daily for 12 weeks. Researchers will measure changes in acne severity …

This study is testing whether Sculptra injections can safely improve the appearance of skin irregularities on the buttocks. About 125 women aged 18+ with moderate to severe skin laxity will receive injections or no treatment for comparison. Researchers will measure how much the s…

This study is testing an injectable drug called nemolizumab to see if it can reduce severe, long-term itching that has no known cause. About 50 adults with this condition will receive either the drug or a placebo for 16 weeks. The main goal is to understand how the drug moves thr…

This study is testing a topical skincare product to see if it improves the look and feel of crepey, aging skin. About 30 adults aged 40-60 with mild-to-moderate skin crepiness will apply the product to their body for 12 weeks. Researchers will measure changes in skin texture, hyd…

This study aims to understand how a cosmetic treatment called Sculptra (poly L-lactic acid) changes the skin of menopausal women with moderate-to-severe cheek wrinkles. Researchers will enroll about 40 women and take small skin samples (punch biopsies) before and after treatment …

This study aims to understand how the cosmetic treatment Sculptra changes the structure of skin in the cheek area. Researchers will use special imaging cameras to take detailed pictures of the skin of 25 women with moderate-to-severe cheek wrinkles before and after they receive S…